Revvity | PKI - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agilent USD 32.66B 5.2B 2026-03
Align Technology USD 12.28B 1.07B 2026-03
Bio Techne USD 8.18B 987M 2026-03
Bruker USD 5.5B 1.66B 2026-03
Celltrion KRW 37.87T 35.44T 2026-07
Charles River Laboratories USD 7.85B 2.17B 2026-03
Danaher USD 128.29B 10.57B 2026-07
Dentsply International USD 2.32B 36M 2026-03
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 2.71B 1.87B 2026-07
Divis Laboratories Ltd INR 1.58T 118.27B 2026-03
Edwards Lifesciences USD 46.17B 3.3B 2026-03
Illumina USD 17.88B 2.74B 2026-03
Intuitive Surgical USD 142.77B 1.93B 2026-07
IQVIA Holdings USD 28.63B 9.76B 2026-03
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Laboratory Of America USD 21.93B 1.13B 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Mettler Toledo International USD 25.54B 2.94B 2026-03
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Organigram Holdings CAD 136.51M 115.96M 2026-07
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pacific Biosciences Of California USD 565M 180M 2025-12
Pharma Mar EUR 1.57B 225M 2026-03
Qiagen NV USD 8.27B 1.62B 2026-03
Quest Diagnostics USD 21.69B 2.39B 2026-03
Quidel USD 1.01B 984M 2026-03
Repligen USD 6.64B 2.58B 2026-03
Revvity USD 9.94B 1.03B 2026-03
Sartorius EUR 14.25B 2.16B 2026-03
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Waters USD 29.87B 7.25B 2026-03
Zealand Pharma A/S 33.35B 448.34M 2025-12